230 related articles for article (PubMed ID: 19705288)
21. Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China.
Wu D; Cai L; Huang M; Zheng Y; Yu J
Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):86-90. PubMed ID: 20226583
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
Zhang L; Bi Q; Deng H; Xu J; Chen J; Zhang M; Mu X
BMC Infect Dis; 2017 Jan; 17(1):107. PubMed ID: 28143439
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus types 16, 18, and 45 in women with cervical intraepithelial changes: associations with colposcopic and histological findings.
Jarienė K; Vaitkienė D; Bartusevičius A; Tvarijonavičienė E; Minkauskienė M; Nadišauskienė R; Kruminis V; Kliučinskas M
Medicina (Kaunas); 2012; 48(1):22-30. PubMed ID: 22481371
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
Carozzi FM; Tornesello ML; Burroni E; Loquercio G; Carillo G; Angeloni C; Scalisi A; Macis R; Chini F; Buonaguro FM; Giorgi Rossi P;
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2389-400. PubMed ID: 20826836
[TBL] [Abstract][Full Text] [Related]
25. Association between HPV types and species groups and cervical neoplasia from a high-risk area for cervical cancer, Goiânia, Brazil.
Ribeiro AA; Figueiredo Alves RR; Costa MC; Villa LL; Zeferino LC; Mauricette Derchain SF; Dos Santos Carneiro MA; Rabelo-Santos SH
Int J Gynecol Pathol; 2011 May; 30(3):288-94. PubMed ID: 21464724
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study.
Prétet JL; Jacquard AC; Saunier M; Clavel C; Dachez R; Gondry J; Pradat P; Soubeyrand B; Leocmach Y; Mougin C; Riethmuller D;
Gynecol Oncol; 2008 Aug; 110(2):179-84. PubMed ID: 18514800
[TBL] [Abstract][Full Text] [Related]
27. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
[TBL] [Abstract][Full Text] [Related]
28. Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta.
Murdiyarso LS; Kartawinata M; Jenie I; Widjajahakim G; Hidajat H; Sembiring R; Nasar IM; Cornain S; Sastranagara F; Utomo AR
Cancer Causes Control; 2016 Nov; 27(11):1371-1379. PubMed ID: 27752850
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.
Correnti M; Medina F; Cavazza ME; Rennola A; Avila M; Fernándes A
Gynecol Oncol; 2011 Jun; 121(3):527-31. PubMed ID: 21421263
[TBL] [Abstract][Full Text] [Related]
30. Comparative Study on Detection and Typing of Human Papillomavirus (HPV) Infection with Microarray Using Paraffin-Embedded Specimens from Squamous Cell Carcinoma and Cervical Precursor Lesions.
Gong P; Wang Z; Geng J; Tan X
J Nanosci Nanotechnol; 2017 Feb; 17(2):990-97. PubMed ID: 29671971
[TBL] [Abstract][Full Text] [Related]
31. Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran.
Heydari N; Oskouee MA; Vaezi T; Shoja Z; Esmaeili HA; Hamkar R; Shahmahmoodi S; Jalilvand S
J Med Virol; 2018 Jan; 90(1):172-176. PubMed ID: 28786495
[TBL] [Abstract][Full Text] [Related]
32. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women.
Kim J; Kim BK; Lee CH; Seo SS; Park SY; Roh JW
Int J Gynecol Cancer; 2012 Nov; 22(9):1570-6. PubMed ID: 23051954
[TBL] [Abstract][Full Text] [Related]
35. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
Kang YJ; Lewis H; Smith MA; Simonella L; Neal H; Bromhead C; Canfell K
BMC Infect Dis; 2015 Aug; 15():365. PubMed ID: 26297490
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
[TBL] [Abstract][Full Text] [Related]
37. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
[No Abstract] [Full Text] [Related]
38. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt.
Abd El-Azim S; Lotfy M; Omr A
Clin Lab; 2011; 57(5-6):363-71. PubMed ID: 21755827
[TBL] [Abstract][Full Text] [Related]
39. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
Harbhajanka A; Dahoud W; Michael CW
Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
[TBL] [Abstract][Full Text] [Related]
40. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
